A3P Biomedical provides prostate cancer diagnosis and treatment. They specialize in advanced prostate cancer diagnostics. Their main product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. The test combines protein markers, genetic markers, and clinical data in a proprietaryalgorithm for the purpose of detecting aggressive prostate cancer at an early stage.

Biotechnology

Health Care

Health Diagnostics

Life Sciences

A3P Biomedical

Maria Jansson

Tobias Wilnier

The Laboratory Team at A3P Biomedical is responsible for conducting high-precision blood tests using the company's proprietary Stockholm3 algorithm. They handle sample processing, data collection, and analysis of protein and genetic markers to support early detection of aggressive prostate cancer. The team ensures laboratory operations adhere to clinical standards and continuously improves testing protocols through research and development efforts.

Laboratory Team

About

Team members